Industry leaders explored the risks and benefits of adopting a China Plus One strategy at Advamed’s The MedTech Conference in ...

On Tuesday, Johnson & Johnson (NYSE:JNJ) reported a third-quarter adjusted EPS of $2.42, down 9.0% year-over-year, beating ...

Abbott Laboratories raised its 2024 earnings guidance after strong Q3 results, driven by growth in Pharma and MedTech ...

Here are eight key developments from spine and orthopedic devicemakers since Oct. 9. 1. Johnson & Johnson MedTech began the ...

"Make sure that when you build your products, you're thinking about it as an open platform," Nvidia's Mostafa Toloui said ...

Novocure received a long-sought FDA approval for the use of its Tumor Treating Fields technology against metastatic non-small ...

Passionate about returning Big Pharma's power to the people, Marc DeValera, founder of MLFD-MedTech Inc., developed 3 ...

TORONTO—NYU Langone Health has tapped Philips to help take its pathology program fully digital—including translating its ...

Stryker's 8% CAGR revenue growth over the past 12 years was driven by organic growth and acquisitions. Learn more about SYK ...

Q3 2024 Earnings Call Transcript October 15, 2024 Johnson & Johnson beats earnings expectations. Reported EPS is $2.42, ...

Visakhapatnam: Union Minister of State for the Ministry of Skill Development and Entrepreneurship and Minister of State for ...

Jefferies analyst Matthew Taylor maintained a Hold rating on Abbott Laboratories (ABT – Research Report) today and set a price target of ...